Gastroparesis Drugs Market Anticipated to Reach US$ 6,662.35 Million, with a CAGR of 4.4% from 2024 to 2032

According to Polaris Market Research's latest market analysis, "Gastroparesis Drugs Market by Drug Class (Prokinetic Agents, Antiemetic Agents, and Botulinum Toxin Injections), Disease Class, End User, Region-Global Forecast to 2032," the market size for gastroparesis drugs is expected to increase from USD 4,529.75 million in 2023 to USD 6,662.35 million by 2032, exhibiting a CAGR of 4.4% from 2024 to 2032.

The disorder known as gastroparesis harms your stomach's muscles' natural, spontaneous motility. Powerful muscle contractions usually move food through your digestive system.
However, gastroparesis prevents your stomach from emptying properly because it slows down or stops working altogether. In addition to impairing regular digestion, gastroparesis can result in vomiting, nausea, and pain in the abdomen. Nutritional issues and blood sugar issues may also result from it. Medication and dietary modifications can help some people feel better.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: @ https://www.polarismarketresearch.com/industry-analysis/gastroparesis-drugs-market/request-for-sample

Prominent Participants

The research study contains information about market companies and thorough analyses of the competitive landscape of the industry, such as:

𝗞𝗲𝘆 𝗧𝗮𝗸𝗲𝗮𝘄𝗮𝘆𝘀

● The need for gastroparesis medications is being driven primarily by two factors: the sharp rise in the number of surgical procedures that resulted in an increased incidence of post-surgical gastroparesis and the rapid global increase in the prevalence of idiopathic gastroparesis.

● In 2023, North America dominated the gastroparesis drugs market.

● Europe is expected to grow at a quick rate during the forecast period.

𝗧𝗵𝗲 𝗠𝗮𝗷𝗼𝗿 𝗣𝗹𝗮𝘆𝗲𝗿𝘀 𝗢𝗽𝗲𝗿𝗮𝘁𝗶𝗻𝗴 𝗜𝗻 𝗧𝗵𝗲 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗔𝗿𝗲:

• Abbott Laboratories (US)
• AbbVie Inc. (US)
• Allergan Inc. (US)
• Evoke Pharma (US)
• Medtronic Plc (Ireland)
• Neurogastrx Inc. (US)
• Pfizer Inc. (US)
• Rhythm Pharmaceuticals Inc. (US)
• Salix Pharmaceuticals (US)
• TEVA Pharmaceutical (Israel)
• Vanda Pharmaceuticals Inc. (US)

𝐁𝐮𝐲 𝐭𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭: @ https://www.polarismarketresearch.com/buy/3710/2

𝗠𝗮𝗿𝗸𝗲𝘁 𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻

According to insights on pharmacological classes, the prokinetic agents segment held the highest share in 2023. Segment's popularity is ascribed to its extensive application, which enhances stomach motility and increases stomach muscular contractions. Furthermore, the pharmacy segment is expected to develop at the fastest rate, according to end-user insights. The growth of this sector can be attributed to several factors, including patients' ease of access to pharmacies for the purchase of medications related to gastroparesis and other related treatments, the ongoing expansion of retail pharmacy chains, and their emphasis on developing an online presence.

𝗚𝗮𝘀𝘁𝗿𝗼𝗽𝗮𝗿𝗲𝘀𝗶𝘀 𝗗𝗿𝘂𝗴𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 𝗥𝗲𝗽𝗼𝗿𝘁 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀

• Prokinetic agents segment accounted for noteworthy share in 2023, that is due to its ability to boost stomach muscles contractions and movement
• Diabetic gastroparesis segment held the maximum share in 2023, owing to significant prevalence of diabetes due to change in people lifestyle and consumption patterns
• Pharmacies segment will grow at highest pace during forecast period, that is attributed to significant expansion of retail pharmacy chains and easy accessibility to patients
• North America dominated the global market in 2023, on account of rising prevalence of diabetes and presence of advanced healthcare infrastructure

𝐁𝐫𝐨𝐰𝐬𝐞 𝐦𝐨𝐫𝐞 𝐃𝐞𝐭𝐚𝐢𝐥𝐬: @ https://www.polarismarketresearch.com/industry-analysis/gastroparesis-drugs-market

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:
𝐆𝐚𝐬𝐭𝐫𝐨𝐩𝐚𝐫𝐞𝐬𝐢𝐬 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭:

• Prokinetic Agents
• Antiemetic Agents
• Botulinum Toxin Injections

𝐁𝐲 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐂𝐥𝐚𝐬𝐬:

• Diabetic Gastroparesis
• Idiopathic Gastroparesis
• Post-surgical Gastroparesis
• Others

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

Human Growth Hormone Market: https://www.openpr.com/news/3439952/human-growth-hormone-market-share-trend-analysis-is-expected

Mental Health Screening Market: https://www.openpr.com/news/3440370/mental-health-screening-market-poised-for-usd-2379-05-million

Central Lab Market: https://www.openpr.com/news/3441880/central-lab-market-envisioned-at-usd-5-55-billion-by-2032-with

Analytical Standards Market: https://www.openpr.com/news/3442124/analytical-standards-market-size-and-share-analysis-is-expected

𝗖𝗼𝗻𝘁𝗮𝗰𝘁 𝗨𝘀:

Polaris Market Research
Email: sales@polarismarketresearch.com
Ph: +1-929 297-9727

𝗔𝗯𝗼𝘂𝘁 𝗨𝘀:

Polaris Market Research is a worldwide market research and consulting organization.
We give unmatched nature of offering to our customers present all around the globe across industry verticals.
Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.
We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

This release was published on openPR.